Raymond James & Associates’s Aerie Pharmaceuticals, Inc. AERI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q3
Sell
-42,662
Closed -$683K 4086
2021
Q2
$683K Buy
42,662
+914
+2% +$14.6K ﹤0.01% 2845
2021
Q1
$746K Buy
41,748
+1,126
+3% +$20.1K ﹤0.01% 2702
2020
Q4
$549K Sell
40,622
-31
-0.1% -$419 ﹤0.01% 2733
2020
Q3
$478K Sell
40,653
-1,587
-4% -$18.7K ﹤0.01% 2646
2020
Q2
$623K Buy
42,240
+215
+0.5% +$3.17K ﹤0.01% 2440
2020
Q1
$567K Buy
42,025
+7,389
+21% +$99.7K ﹤0.01% 2330
2019
Q4
$837K Sell
34,636
-15,681
-31% -$379K ﹤0.01% 2375
2019
Q3
$967K Buy
50,317
+39
+0.1% +$750 ﹤0.01% 2220
2019
Q2
$1.49M Buy
+50,278
New +$1.49M ﹤0.01% 1971
2018
Q4
Sell
-17,175
Closed -$1.06M 3587
2018
Q3
$1.06M Sell
17,175
-8,399
-33% -$517K ﹤0.01% 2222
2018
Q2
$1.73M Buy
25,574
+120
+0.5% +$8.11K ﹤0.01% 1853
2018
Q1
$1.38M Sell
25,454
-31,440
-55% -$1.71M ﹤0.01% 1923
2017
Q4
$3.4M Sell
56,894
-1,739
-3% -$104K 0.01% 1350
2017
Q3
$2.85M Buy
58,633
+792
+1% +$38.5K 0.01% 1401
2017
Q2
$3.04M Sell
57,841
-24,552
-30% -$1.29M 0.01% 1309
2017
Q1
$3.74M Sell
82,393
-30,639
-27% -$1.39M 0.01% 1165
2016
Q4
$4.28M Sell
113,032
-3,897
-3% -$147K 0.01% 1068
2016
Q3
$4.41M Buy
116,929
+64,366
+122% +$2.43M 0.01% 1014
2016
Q2
$925K Buy
52,563
+3,411
+7% +$60K ﹤0.01% 1774
2016
Q1
$598K Sell
49,152
-3,987
-8% -$48.5K ﹤0.01% 1952
2015
Q4
$1.29M Sell
53,139
-4,057
-7% -$98.8K ﹤0.01% 1494
2015
Q3
$1.02M Sell
57,196
-34,934
-38% -$620K ﹤0.01% 1591
2015
Q2
$1.63M Buy
92,130
+38,199
+71% +$674K 0.01% 1443
2015
Q1
$1.69M Buy
+53,931
New +$1.69M 0.01% 1341
2014
Q4
Sell
-12,000
Closed -$248K 2314
2014
Q3
$248K Buy
+12,000
New +$248K ﹤0.01% 2097